- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00787696
Healthy Teen Girls: HIV Risk Reduction
HIV Risk Reduction Among Young Incarcerated Females
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This study is a longitudinal analysis of STD/HIV exposure among adolescent female offenders in Mississippi, a population that is disproportionately African American, and at higher risk than adolescents in general due to their propensity to engage in a variety of risk-taking behaviors, earlier onset of sexual behaviors, and the greater prevalence of mental disorders, substance abuse disorders, maltreatment, and family dysfunction. Based on social cognitive theory and Fisher and Fisher's (1992) IMB (Information, Motivation, and Behavioral skills) model, we will evaluate a drug abuse related HIV risk reduction intervention and compare outcomes against a STD/HIV information and health education control condition.
Approximately 400 females committed to the state reformatory/training school for girls will be recruited for participation. The research design will consist of alternating cohort/waves of about 50 subjects each. One treatment condition will be administered at a time with a washout period between cohort/waves. Over a three year period, one half of subjects will get 18 hours of STD/HIV prevention and one half will get 18 hours of Health Education. All subjects will receive one individual counseling session designed to enhance motivation for behavioral change just prior to release from training school. Before and after the intervention, subjects' social competency skills, condom application skills, and health knowledge will be measured. Before intervention and at 6-month and 12-month follow-up, self-report measures of alcohol and drug use, condom use, sexual risk behaviors, and measures of victimization, partner risk, condom attitudes, self-efficacy, and communication related to condom use and risk reduction will be collected. Urine tests for the detection of 2 STDs (chlamydia and gonorrhea) will also be performed at admission to Columbia Training School and at 6-month and 12-month follow-up.
Study Type
Enrollment (Actual)
Phase
- Phase 2
- Phase 1
Contacts and Locations
Study Locations
-
-
Mississippi
-
Columbia, Mississippi, United States, 39429
- Columbia Training School
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Female, ages 13 to 17 years, committed to Columbia Training School, who provide written informed assent.
Exclusion Criteria:
- Acute or chronic physically illness that would preclude participation as determined by facility physician; placement in maximum security unit; study participation during a prior commitment
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Skills Training
intervention group received information, motivation and skills training: condom application, assertive communication & problem solving
|
18 60-minute group sessions plus 1 individual health and safety planning session
|
Active Comparator: Health Education
Comparsion group received information and motivation
|
18 60-minute group sessions plus 1 individual health and safety planning session
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
number of partners and frequency of sexual risk behaviors
Time Frame: at 6 & 12 months
|
Sexual behaviors included condom use in the 3 months prior to each assessment.
Unprotected sex occasions (USOs) was calculated by subtracting the number of condom-protected vaginal and anal intercourse occasions from the total number of vaginal and anal intercourse occasions.
Sex under the influence is the number of times participant reported sexual intercourse after drinking alcohol or using another drug.
Safer sex was categorized as sexually abstinent or consistent condom use.
|
at 6 & 12 months
|
infection with chlamydia or gonorrhea
Time Frame: one year
|
one year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
reproductive health knowledge
Time Frame: pre and post-intervention
|
Assessed as the number of correct answers to 37 treu/false and multiple choice questions
|
pre and post-intervention
|
condom application skill
Time Frame: pre and post-intervention
|
Measured by observing participants apply and remove a condom from a penile model and a 10-item checklist
|
pre and post-intervention
|
Communication skills
Time Frame: pre and post-intervention
|
Assessed during three role-play vignettes that place the respondent in a high-risk sexual or drug use situation and asked them to respond to a series of three escalating prompts as though the situation was actually happening.
|
pre and post-intervention
|
Perceived barriers to condom use
Time Frame: at baseline, 6 and 12 month follow-up
|
assessed using the Condom Barrier Scale (St.
Lawrence, Chapdeline, et al., 1999)
|
at baseline, 6 and 12 month follow-up
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Angela A. Robertson, Ph.D., Mississippi State University
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- RNA Virus Infections
- Virus Diseases
- Infections
- Blood-Borne Infections
- Communicable Diseases
- Sexually Transmitted Diseases, Viral
- Sexually Transmitted Diseases
- Lentivirus Infections
- Retroviridae Infections
- Immunologic Deficiency Syndromes
- Immune System Diseases
- Slow Virus Diseases
- HIV Infections
- Acquired Immunodeficiency Syndrome
Other Study ID Numbers
- R01DA17509-4
- R01DA017509 (U.S. NIH Grant/Contract)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on HIV-infection/Aids
-
University of MinnesotaWithdrawnHIV Infections | HIV/AIDS | Hiv | AIDS | Aids/Hiv Problem | AIDS and InfectionsUnited States
-
Trieu, Nguyen Thi, M.D.CompletedHIV-1-infection | AIDSVietnam
-
Merck Sharp & Dohme LLCHIV Vaccine Trials NetworkTerminatedHIV Infections | AIDS
-
Peking Union Medical CollegeUnknown
-
ANRS, Emerging Infectious DiseasesPfizerCompleted
-
Peking Union Medical CollegeMinistry of Science and Technology of the People´s Republic of ChinaUnknownAIDS/HIV PROBLEMChina
-
New York UniversityNYU Langone HealthUnknownHIV-infection/AIDSUnited States
-
Tobira Therapeutics, Inc.ViiV HealthcareCompletedHIV-infection/AIDSUnited States
-
Peking Union Medical College HospitalCompleted
-
Rigshospitalet, DenmarkHorizon 2020 - European Commission; IrsiCaixaNot yet recruitingInflammation | HIV-1-infection | AIDSSpain, United Kingdom, Denmark, France, Israel, Germany, Belgium, Croatia, Czechia, Greece, Hungary, Italy, Luxembourg, Poland
Clinical Trials on Cognitive-behavioral HIV/STD risk reduction
-
University of PennsylvaniaNational Institute of Mental Health (NIMH)CompletedHIV Infections | Sexually Transmitted DiseasesUnited States
-
University of PennsylvaniaNational Institute of Mental Health (NIMH); University of California, Los Angeles and other collaboratorsCompletedHIV Infections | Sexually Transmitted DiseaseUnited States
-
University of PennsylvaniaEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompletedSexually Transmitted Diseases | Human Immunodeficiency Virus Infection
-
Columbia UniversityNational Institute of Mental Health (NIMH)Completed
-
University of PennsylvaniaNational Institute on Minority Health and Health Disparities (NIMHD)CompletedHuman Immunodeficiency Virus (HIV) | Sexually Transmitted Disease (STD)United States
-
University of MiamiNational Institute of Allergy and Infectious Diseases (NIAID)Completed
-
University of PennsylvaniaNational Institute of Mental Health (NIMH)CompletedHIV Infections | Sexually Transmitted Disease
-
Emory UniversityAmerican University of ArmeniaCompletedHIV Infections | HIV PreventionArmenia
-
Michele StatonNational Institute on Drug Abuse (NIDA)CompletedHepatitis C | Drug Abuse | Acquired Immune Deficiency Syndrome VirusUnited States
-
National Institute of Allergy and Infectious Diseases...Completed